United States · Bill · HR
H.R. 844 (98th)
A bill to exempt certain blood fractions from the Federal Food, Drug, and Cosmetic Act for five years, and for other purposes.
Introduced
25 January 1983
Last action
—
Status
Referred to Subcommittee on Health and the Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Excludes blood fractions used in immunoaugmentative therapy by the Immunology Researching Center, Limited, of Freeport, Grand Bahama Island, Bahamas, from the definition of drug under the Federal Food, Drug and Cosmetic Act for a period of five years. Expresses the sense of Congress that the Federal Government and the medical profession should cooperate with Dr. Lawrence P. Burton in his cancer research and therapy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
summary · EN · 25 January 1983
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/98th-congress/house-bill/844
- Open data entity: https://api.congress.gov/v3/bill/98/hr/844